What is Exerte Partners' most recent investment?

Exerte Partners most recently invested in OCON Therapeutics, participating in a $24.5M Series A round in June 2024.

What is Exerte Partners' primary sector focus?

Exerte Partners has shown a focus on the Health Tech & Life Sciences sector, with its only recorded investment being in OCON Therapeutics.

What stage of funding does Exerte Partners typically participate in?

Exerte Partners has participated in a Series A round, specifically investing in OCON Therapeutics.

Can you name a notable company in Exerte Partners' portfolio?

A notable company in Exerte Partners' portfolio is OCON Therapeutics, which develops a Spherical Intrauterine Drug Delivery Platform.

Where is Exerte Partners headquartered?

Exerte Partners is headquartered in Greece.

What is the investment range for Exerte Partners?

Exerte Partners' investment range is $10M - $10M.

Exerte Partners

A single family office with a global investment focus, based in Nicosia, Cyprus.

Venture Capital Active Nicosia, Cyprus Est. 2014

Visit website ↗

Last updated 2026-07-20

Portfolio

in our dataset

Rounds participated

Rounds led

Rounds' value

$10.0M

total disclosed, rounds participated

Stages

—

About

Exerte Partners is a single family office based in Nicosia, Cyprus, with a global investment focus. The firm leverages its experience in scaling operations and shaping the vision of companies in traditional and tech sectors to support innovation and sustainability. They began with angel investing, mentoring, and providing in-kind support to the local and regional startup ecosystem. Today, they actively support their portfolio companies by offering strategic capital, network leverage, and guidance for growth. The firm manages private wealth with attention to long-term allocation and risk oversight, targeting seed and Series A investments in AgriTech & FoodTech, Digital Health, and ClimateTech across various geographies.

Portfolio · 1

OCON Therapeutics

Spherical Intrauterine Drug Delivery Platform

1 round $10.0M committed Latest: 2024-06

Investment activity

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Exerte Partners' most recent investment?: Exerte Partners most recently invested in OCON Therapeutics, participating in a $24.5M Series A round in June 2024.
What is Exerte Partners' primary sector focus?: Exerte Partners has shown a focus on the Health Tech & Life Sciences sector, with its only recorded investment being in OCON Therapeutics.
What stage of funding does Exerte Partners typically participate in?: Exerte Partners has participated in a Series A round, specifically investing in OCON Therapeutics.
Can you name a notable company in Exerte Partners' portfolio?: A notable company in Exerte Partners' portfolio is OCON Therapeutics, which develops a Spherical Intrauterine Drug Delivery Platform.
Where is Exerte Partners headquartered?: Exerte Partners is headquartered in Greece.
What is the investment range for Exerte Partners?: Exerte Partners' investment range is $10M - $10M.

Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Website	exerte.com/

Identifiers & details

Legal name	EXERTE PARTNERS LIMITED
Founded	2014-9

Radar intelligence

Web history (Wayback)

Domain	exerte.com

Certificate / subdomain footprint

Subdomains	2